Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hologic, Inc. (HOLX : NSDQ)
 
 • Company Description   
Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

Number of Employees: 7,070

 
 • Price / Volume Information   
Yesterday's Closing Price: $75.20 Daily Weekly Monthly
20 Day Moving Average: 2,591,165 shares
Shares Outstanding: 223.24 (millions)
Market Capitalization: $16,788.02 (millions)
Beta: 0.72
52 Week High: $75.36
52 Week Low: $51.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.08% 0.00%
12 Week 0.53% -0.47%
Year To Date 0.95% 0.43%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
250 CAMPUS DRIVE
-
MARLBOROUGH,MA 01752
USA		 ph: 508-263-2900
fax: 781-890-8031		 michael.watts@hologic.com http://www.hologic.com
 
 • General Corporate Information   
Officers
STEPHEN P. MACMILLAN - Chief Executive Officer; Chairman and President
KARLEEN M. OBERTON - Chief Financial Officer
BENJAMIN J. COHN - Vice President and Corporate Controller
AMY M. WENDELL - Lead Independent Director
CHARLES DOCKENDORFF - Director

Peer Information
Hologic, Inc. (ABMD)
Hologic, Inc. (DMDS)
Hologic, Inc. (CPWY.)
Hologic, Inc. (EQUR)
Hologic, Inc. (ECIA)
Hologic, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 436440101
SIC: 3844
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/07/26
Share - Related Items
Shares Outstanding: 223.24
Most Recent Split Date: 4.00 (2.00:1)
Beta: 0.72
Market Capitalization: $16,788.02 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.08 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.47 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 7.50% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/07/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.82
Trailing 12 Months: 17.57
PEG Ratio: 2.24
Price Ratios
Price/Book: 3.20
Price/Cash Flow: 13.17
Price / Sales: 4.07
EPS Growth
vs. Year Ago Period: 0.97%
vs. Previous Quarter: -7.96%
Sales Growth
vs. Year Ago Period: 2.54%
vs. Previous Quarter: -0.16%
ROE
12/31/25 - 19.58
09/30/25 - 20.13
06/30/25 - 19.69
ROA
12/31/25 - 10.88
09/30/25 - 11.06
06/30/25 - 10.82
Current Ratio
12/31/25 - 4.04
09/30/25 - 3.75
06/30/25 - 3.55
Quick Ratio
12/31/25 - 3.32
09/30/25 - 3.06
06/30/25 - 2.81
Operating Margin
12/31/25 - 23.44
09/30/25 - 23.66
06/30/25 - 23.60
Net Margin
12/31/25 - 13.18
09/30/25 - 13.80
06/30/25 - 13.79
Pre-Tax Margin
12/31/25 - 16.08
09/30/25 - 16.61
06/30/25 - 16.73
Book Value
12/31/25 - 23.50
09/30/25 - 22.69
06/30/25 - 21.77
Inventory Turnover
12/31/25 - 2.86
09/30/25 - 2.82
06/30/25 - 2.76
Debt-to-Equity
12/31/25 - 0.48
09/30/25 - 0.50
06/30/25 - 0.52
Debt-to-Capital
12/31/25 - 32.38
09/30/25 - 33.25
06/30/25 - 34.22
 

Powered by Zacks Investment Research ©